Diagnosis and Classification of the Schizophrenia Spectrum Disorders

More documents

Recommendations

Info

Contributors to Volume III 489Jennifer A. Nolan Center for Child and Family Policy, Social Science ResearchInstitute, Duke University, Durham, NC, USA, jennifer.nolan@duke.edu;jan36@cornell.eduKieron O’Connor Fernand-Seguin Research Centre, Louis-H. LafontaineHospital, University of Montreal, Montreal, QC, Canada; Department ofPsychoeducation and Psychology, University of Quebec in Outaouais, Gatineau,QC, Canada, kieron.oconnor@umontreal.caClaire E. Ramsay Department of Psychiatry and Behavioral Sciences, EmoryUniversity School of Medicine, Atlanta, GA, USA, cramsay@emory.eduMichael Riedel Department of Psychiatry and Psychotherapy,Ludwig-Maximilians-University Munich, München, Germany; Psychiatric Clinic,Vinzenz-von-Paul-Hospital, Rottweil, Germany, Riedel@med.uni-muenchen.deMichael S. Ritsner Department of Psychiatry, Rappaport Faculty of Medicine,Technion – Israel Institute of Technology, Haifa, Israel; Acute Department, Sha’arMenashe Mental Health Center, Hadera, Israel, ritsner@sm.health.gov.il;ritsnerm@gmail.comStephan Ruhrmann Department of Psychiatry and Psychotherapy, UniversityHospital, University of Cologne, Cologne, Germany,stephan.ruhrmann@uk-koeln.deRebecca Schennach-Wolff Department of Psychiatry and Psychotherapy,Ludwig-Maximilians-University Munich, 80336, München, Germany,Rebecca.Schennach-Wolff@med.uni-muenchen.deBenno Graf Schimmelmann University Hospital of Child and AdolescentPsychiatry, University of Bern, Bern, Switzerland,benno.schimmelmann@kjp.unibe.chFrauke Schultze-Lutter University Hospital of Child and Adolescent Psychiatry,University of Bern, Bern, Switzerland, frauke.schultze-lutter@kjp.unibe.chFlorian Seemüller Department of Psychiatry and Psychotherapy,Ludwig-Maximilians-University Munich, München, Germany,Florian.Seemueller@med.uni-muenchen.deIlja Spellmann Department of Psychiatry and Psychotherapy,Ludwig-Maximilians-University Munich, München, Germany,Ilja.Spellmann@med.uni-muenchen.deTomiki Sumiyoshi Department of Neuropsychiatry, University of ToyamaGraduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan,tomikisumiyoshi840@hotmail.comAndrew Thompson Orygen Youth Health, Melbourne Health, North WesternMental Health, Melbourne, VIC, Australia
490 Contributors to Volume IIIKaren F. Vieira Global Neuroscience Initiative Foundation (GNIF), Los Angeles,CA, USA, kvieira@gnif.orgSasha Whaley Department of Psychology, Institute of Psychiatry, London, UK,sasha.whaley@kcl.ac.ukThomas Wobrock Department of Psychiatry and Psychotherapy, UniversityMedical Center Goettingen, Georg-August-University Goettingen, Goettingen,Germany, twobroc@gwdg.deStephen J. Wood University of Birmingham, Birmingham, UK; Department ofPsychiatry, Melbourne Neuropsychiatry Centre, The University of Melbourne andMelbourne Health, Melbourne, VIC, Australia, sjwood@unimelb.edu.auTil Wykes Department of Psychology, Institute of Psychiatry, London, UK,til.wykes@kcl.ac.uk
Page 2:
Handbook of Schizophrenia Spectrum
Page 5 and 6:
EditorMichael S. RitsnerTechnion -
Page 7 and 8:
viForewordpsychotic disorders, gene
Page 9 and 10:
viiiForewordItaly, Israel, Japan, S
Page 11 and 12:
xContents9 Schizophrenia Has a High
Page 13 and 14:
This is Blank Page Integraxii
Page 15 and 16:
xivContributorsBrazil; Laboratory o
Page 17 and 18:
xviContributorsLuca De Peri Departm
Page 19 and 20:
Chapter 1The Schizophrenia Construc
Page 21 and 22:
1 The Schizophrenia Construct After
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Chapter 2Diagnosis and Classificati
Page 65 and 66:
2 Diagnosis and Classification of t
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
86 M.S. RitsnerKeywords Functional
Page 105 and 106:
88 M.S. RitsnerProof-of-Concept for
Page 107 and 108:
90 M.S. RitsnerTable 3.1 Measuring
Page 109 and 110:
92 M.S. RitsnerTable 3.2 Definition
Page 111 and 112:
94 M.S. RitsnerFactor Structure: Th
Page 113 and 114:
96 M.S. RitsnerFig. 3.4 Frequency o
Page 115 and 116:
98 M.S. RitsnerPatients Sex Age(yr.
Page 117 and 118:
100 M.S. RitsnerTable 3.4 Frequency
Page 119 and 120:
102 M.S. Ritsner1. A genetic load h
Page 121 and 122:
104 M.S. Ritsnerneuronal function a
Page 123 and 124:
106 M.S. RitsnerMulti-dimensional p
Page 125 and 126:
108 M.S. Ritsner39. Fink M (2009) C
Page 127 and 128:
110 M.S. Ritsner82. Walsh T, McClel
Page 129 and 130:
112 M.S. Ritsner125. Kissling W, He
Page 131 and 132:
Chapter 4Irving Gottesman and the S
Page 133 and 134:
4 Irving Gottesman and the Schizoph
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
128 M.F. LenzenwegerKeywords Schizo
Page 145 and 146:
130 M.F. LenzenwegerReactionsSchizo
Page 147 and 148:
132 M.F. Lenzenwegerorganize resear
Page 149 and 150:
134 M.F. Lenzenwegerdone recently b
Page 151 and 152:
136 M.F. Lenzenwegerwith a “story
Page 153 and 154:
138 M.F. Lenzenwegernot be true (se
Page 155 and 156:
140 M.F. Lenzenweger3. Rado S (1960
Page 157 and 158:
Chapter 6Autistic Spectrum Disorder
Page 159 and 160:
6 Autistic Spectrum Disorders and S
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Chapter 7One Hundred Years of Insan
Page 179 and 180:
7 One Hundred Years of Insanity 165
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
188 A.R. Rădulescutreatment can be
Page 203 and 204:
190 A.R. Rădulescupathways have no
Page 205 and 206:
192 A.R. Rădulescukey functions re
Page 207 and 208:
194 A.R. Rădulescuincreasing insta
Page 209 and 210:
196 A.R. Rădulescucorrections of t
Page 211 and 212:
198 A.R. RădulescuQuantifying Schi
Page 213 and 214:
200 A.R. RădulescuTable 8.1 Profil
Page 215 and 216:
202 A.R. RădulescuFig. 8.4 Princip
Page 217 and 218:
204 A.R. RădulescuFig. 8.5 Charact
Page 219 and 220:
206 A.R. Rădulescuto use discrete
Page 221 and 222:
208 A.R. RădulescuAppendix 1: Simp
Page 223 and 224:
210 A.R. RădulescuStudy design, ta
Page 225 and 226:
212 A.R. Rădulescu35. Kitzbichler
Page 227 and 228:
214 A.R. Rădulescu83. Shibata T, T
Page 229 and 230:
216 A.R. Rădulescu132. Rosenkranz
Page 231 and 232:
Chapter 9Schizophrenia Has a High H
Page 233 and 234:
9 Schizophrenia Has a High Heritabi
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Chapter 10Changes in Gene Expressio
Page 251 and 252:
10 Changes in Gene Expression 239ge
Page 253 and 254:
10 Changes in Gene Expression 241Ta
Page 255 and 256:
10 Changes in Gene Expression 243fu
Page 257 and 258:
10 Changes in Gene Expression 245ex
Page 259 and 260:
10 Changes in Gene Expression 247el
Page 261 and 262:
10 Changes in Gene Expression 24941
Page 263 and 264:
10 Changes in Gene Expression 25184
Page 265 and 266:
254 G.B. Baker et al.fMRIGABAGTIHPL
Page 267 and 268:
256 G.B. Baker et al.[20-26]. Glyci
Page 269 and 270:
258 G.B. Baker et al.suggesting bot
Page 271 and 272:
260 G.B. Baker et al.14. Labrie V,
Page 273 and 274:
262 G.B. Baker et al.54. Palsson E,
Page 275 and 276:
264 S.L. Bronson and N.M. RichtandA
Page 277 and 278:
266 S.L. Bronson and N.M. Richtandt
Page 279 and 280:
268 S.L. Bronson and N.M. RichtandP
Page 281 and 282:
270 S.L. Bronson and N.M. Richtandi
Page 283 and 284:
272 S.L. Bronson and N.M. RichtandB
Page 285 and 286:
274 S.L. Bronson and N.M. Richtandm
Page 287 and 288:
276 S.L. Bronson and N.M. RichtandG
Page 289 and 290:
278 S.L. Bronson and N.M. RichtandB
Page 291 and 292:
280 S.L. Bronson and N.M. Richtandp
Page 293 and 294:
282 S.L. Bronson and N.M. Richtand3
Page 295 and 296:
284 S.L. Bronson and N.M. Richtand8
Page 297 and 298:
Chapter 13Glutamatergic Neurotransm
Page 299 and 300:
13 Glutamatergic Neurotransmission
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Chapter 14Mathematical Models in Sc
Page 317 and 318:
14 Mathematical Models in Schizophr
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
328 C.A. Bousman et al.Introduction
Page 339 and 340:
330 C.A. Bousman et al.prolonged. B
Page 341 and 342:
332 C.A. Bousman et al.Biomarker Di
Page 343 and 344:
334 C.A. Bousman et al.Table 15.3 G
Page 345 and 346:
336 C.A. Bousman et al.precision th
Page 347 and 348:
338 C.A. Bousman et al.15. United N
Page 349 and 350:
340 C.A. Bousman et al.60. Ikeda M,
Page 351 and 352:
342 C.A. Bousman et al.98. Scott JC
Page 353 and 354:
Chapter 16What Does Proteomics Tell
Page 355 and 356:
16 What Does Proteomics Tell Us Abo
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Chapter 17TheRoleof3α-Hydroxy-5α-
Page 377 and 378:
17 The Role of 3α-Hydroxy-5α-Preg
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Chapter 18Neural Substrates of Emot
Page 415 and 416:
18 Neural Substrates of Emotion Dys
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
432 A. Vita et al.AbbreviationsBD B
Page 441 and 442:
434 A. Vita et al.Bipolar DisorderA
Page 443 and 444: 436 A. Vita et al.temporale, and ca
Page 445 and 446: 438 A. Vita et al.Among the many po
Page 447 and 448: 440 A. Vita et al.22. Hietala J, Ca
Page 449 and 450: 442 A. Vita et al.60. Peters BD, de
Page 451 and 452: Chapter 20Mapping Prodromal Psychos
Page 453 and 454: 20 Mapping Prodromal Psychosis 447i
Page 455 and 456: 20 Mapping Prodromal Psychosis 449t
Page 457 and 458: 20 Mapping Prodromal Psychosis 451F
Page 459 and 460: 20 Mapping Prodromal Psychosis 453s
Page 463 and 464: 20 Mapping Prodromal Psychosis 457o
Page 465 and 466: 20 Mapping Prodromal Psychosis 459N
Page 467 and 468: 20 Mapping Prodromal Psychosis 461T
Page 471 and 472: 20 Mapping Prodromal Psychosis 465p
Page 473 and 474: 20 Mapping Prodromal Psychosis 4673
Page 479 and 480: 474 Afterwordon the current paradig
Page 481 and 482: 476 Afterwordpsychiatric disorders
Page 483 and 484: 478 Contents to Volume II10 Schizop
Page 485 and 486: 480 Contents to Volume III10 Revisi
Page 487 and 488: 482 Contributors to Volume IIRuth C
Page 489 and 490: 484 Contributors to Volume IIGary R
Page 492 and 493: Contributors to Volume IIIAnthony O
Page 496 and 497: IndexAAcute transient psychosis, 5,
Page 498 and 499: Index 493Impairment, 7, 18, 20-22,
show all

Diagnosis and Classification of the Schizophrenia Spectrum Disorders

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?